385 related articles for article (PubMed ID: 1682039)
21. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
Radulovic S; Comaru-Schally AM; Milovanovic S; Schally AV
Pancreas; 1993 Jan; 8(1):88-97. PubMed ID: 8093555
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
Radulovic S; Schally AV; Reile H; Halmos G; Szepeshazi K; Groot K; Milovanovic S; Miller G; Yano T
Acta Oncol; 1994; 33(6):693-701. PubMed ID: 7946450
[TBL] [Abstract][Full Text] [Related]
23. The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice.
Meller CA; Henriques JA; Schwartsmann G; Roesler R
Peptides; 2004 Apr; 25(4):585-8. PubMed ID: 15165713
[TBL] [Abstract][Full Text] [Related]
24. Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.
Szepeshazi K; Schally AV; Rick FG; Block NL; Vidaurre I; Halmos G; Szalontay L
Anticancer Drugs; 2012 Oct; 23(9):906-13. PubMed ID: 22926257
[TBL] [Abstract][Full Text] [Related]
25. Presence of membrane binding sites for [D-TRP6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer.
Fekete M; Zalatnai A; Schally AV
Cancer Lett; 1989 May; 45(2):87-91. PubMed ID: 2567204
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.
Pour PM; Kazakoff K; Carlson K
Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330
[TBL] [Abstract][Full Text] [Related]
27. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.
Szende B; Zalatnai A; Schally AV
Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1643-7. PubMed ID: 2564204
[TBL] [Abstract][Full Text] [Related]
28. Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
Pinski J; Yano T; Groot K; Cai RZ; Radulovic S; Schally AV
Am J Physiol; 1992 Oct; 263(4 Pt 1):E712-7. PubMed ID: 1415689
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer in the Syrian hamster induced by N-nitrosobis(2-oxopropyl)-amine: cocarcinogenic effect of epidermal growth factor.
Chester JF; Gaissert HA; Ross JS; Malt RA
Cancer Res; 1986 Jun; 46(6):2954-7. PubMed ID: 3009003
[TBL] [Abstract][Full Text] [Related]
30. Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K
Int J Cancer; 1993 Dec; 55(6):963-7. PubMed ID: 7902829
[TBL] [Abstract][Full Text] [Related]
31. Alterations of EGFR/HER, angiogenesis and apoptosis pathways after therapy with antagonists of growth hormone releasing hormone and bombesin in non-small cell lung cancer.
Kanashiro CA; Schally AV; Zarandi M; Hammann BD; Varga JL
Int J Oncol; 2007 Apr; 30(4):1019-28. PubMed ID: 17332943
[TBL] [Abstract][Full Text] [Related]
32. Membrane receptors for peptides in experimental and human pancreatic cancers.
Fekete M; Zalatnai A; Comaru-Schally AM; Schally AV
Pancreas; 1989; 4(5):521-8. PubMed ID: 2573055
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
Stangelberger A; Schally AV; Varga JL; Zarandi M; Szepeshazi K; Armatis P; Halmos G
Clin Cancer Res; 2005 Jan; 11(1):49-57. PubMed ID: 15671527
[TBL] [Abstract][Full Text] [Related]
34. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
Kiaris H; Schally AV; Sun B; Armatis P; Groot K
Oncogene; 1999 Nov; 18(50):7168-73. PubMed ID: 10597318
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II.
Jungwirth A; Schally AV; Halmos G; Groot K; Szepeshazi K; Pinski J; Armatis P
Cancer; 1998 Mar; 82(5):909-17. PubMed ID: 9486581
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice.
Pinski J; Halmos G; Schally AV
Cancer Lett; 1993 Jul; 71(1-3):189-96. PubMed ID: 8103419
[TBL] [Abstract][Full Text] [Related]
38. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
Chatzistamou I; Schally AV; Sun B; Armatis P; Szepeshazi K
Br J Cancer; 2000 Oct; 83(7):906-13. PubMed ID: 10970693
[TBL] [Abstract][Full Text] [Related]
40. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
Williams BY; Schonbrunn A
Cancer Res; 1994 Feb; 54(3):818-24. PubMed ID: 8306345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
